These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 29137335)
1. Inhibition of cell cycle progression by the hydroxytyrosol-cetuximab combination yields enhanced chemotherapeutic efficacy in colon cancer cells. Terzuoli E; Nannelli G; Frosini M; Giachetti A; Ziche M; Donnini S Oncotarget; 2017 Oct; 8(47):83207-83224. PubMed ID: 29137335 [TBL] [Abstract][Full Text] [Related]
2. Hydroxytyrosol, a product from olive oil, reduces colon cancer growth by enhancing epidermal growth factor receptor degradation. Terzuoli E; Giachetti A; Ziche M; Donnini S Mol Nutr Food Res; 2016 Mar; 60(3):519-29. PubMed ID: 26577496 [TBL] [Abstract][Full Text] [Related]
3. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells. Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451 [TBL] [Abstract][Full Text] [Related]
4. Cetuximab enhances the activities of irinotecan on gastric cancer cell lines through downregulating the EGFR pathway upregulated by irinotecan. Liu X; Guo WJ; Zhang XW; Cai X; Tian S; Li J Cancer Chemother Pharmacol; 2011 Oct; 68(4):871-8. PubMed ID: 21286718 [TBL] [Abstract][Full Text] [Related]
5. Pingyangmycin downregulates the expression of EGFR and enhances the effects of cetuximab on esophageal cancer cells and the xenograft in athymic mice. Gong JH; Liu XJ; Li Y; Zhen YS Cancer Chemother Pharmacol; 2012 May; 69(5):1323-32. PubMed ID: 22311160 [TBL] [Abstract][Full Text] [Related]
6. Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators. Cerda SR; Mustafi R; Little H; Cohen G; Khare S; Moore C; Majumder P; Bissonnette M Oncogene; 2006 May; 25(22):3123-38. PubMed ID: 16434969 [TBL] [Abstract][Full Text] [Related]
7. EGFR blockade by cetuximab alone or as combination therapy for growth control of hepatocellular cancer. Huether A; Höpfner M; Baradari V; Schuppan D; Scherübl H Biochem Pharmacol; 2005 Nov; 70(11):1568-78. PubMed ID: 16226226 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of colon cancer cell proliferation by the dietary compound conjugated linoleic acid is mediated by the CDK inhibitor p21CIP1/WAF1. Lim DY; Tyner AL; Park JB; Lee JY; Choi YH; Park JH J Cell Physiol; 2005 Oct; 205(1):107-13. PubMed ID: 15880444 [TBL] [Abstract][Full Text] [Related]
9. Indole-3-carbinol (I3C) induced cell growth inhibition, G1 cell cycle arrest and apoptosis in prostate cancer cells. Chinni SR; Li Y; Upadhyay S; Koppolu PK; Sarkar FH Oncogene; 2001 May; 20(23):2927-36. PubMed ID: 11420705 [TBL] [Abstract][Full Text] [Related]
10. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis. Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069 [TBL] [Abstract][Full Text] [Related]
11. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells. Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919 [TBL] [Abstract][Full Text] [Related]
12. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor. Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342 [TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis. Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458 [TBL] [Abstract][Full Text] [Related]
14. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis. Park WH; Kim ES; Kim BK; Lee YY Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794 [TBL] [Abstract][Full Text] [Related]
16. The effects of cetuximab alone and in combination with radiation and/or chemotherapy in lung cancer. Raben D; Helfrich B; Chan DC; Ciardiello F; Zhao L; Franklin W; Barón AE; Zeng C; Johnson TK; Bunn PA Clin Cancer Res; 2005 Jan; 11(2 Pt 1):795-805. PubMed ID: 15701870 [TBL] [Abstract][Full Text] [Related]
17. Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting. Matar P; Rojo F; Cassia R; Moreno-Bueno G; Di Cosimo S; Tabernero J; Guzmán M; Rodriguez S; Arribas J; Palacios J; Baselga J Clin Cancer Res; 2004 Oct; 10(19):6487-501. PubMed ID: 15475436 [TBL] [Abstract][Full Text] [Related]
18. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells. Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376 [TBL] [Abstract][Full Text] [Related]
19. Anti-epidermal growth factor receptor monoclonal antibody 225 upregulates p27(KIP1) and p15(INK4B) and induces G1 arrest in oral squamous carcinoma cell lines. Kiyota A; Shintani S; Mihara M; Nakahara Y; Ueyama Y; Matsumura T; Tachikawa T; Wong DT Oncology; 2002; 63(1):92-8. PubMed ID: 12187077 [TBL] [Abstract][Full Text] [Related]
20. Piperine, an alkaloid from black pepper, inhibits growth of human colon cancer cells via G1 arrest and apoptosis triggered by endoplasmic reticulum stress. Yaffe PB; Power Coombs MR; Doucette CD; Walsh M; Hoskin DW Mol Carcinog; 2015 Oct; 54(10):1070-85. PubMed ID: 24819444 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]